LIVN
LIVN
NASDAQ · Health Care

Livanova Plc

$78.01
+0.22 (+0.28%)
Financial Highlights (FY 2026)
Revenue
1.40B
Net Income
-244,205,508
Gross Margin
67.7%
Profit Margin
-17.5%
Rev Growth
+10.8%
D/E Ratio
0.31
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 67.7% 67.7% 56.7% 56.7%
Operating Margin 14.1% 12.7% 20.0% 18.3%
Profit Margin -17.5% -16.6% 16.6% 15.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.40B 1.26B 866.49M 838.17M
Gross Profit 946.57M 854.69M 491.05M 475.01M
Operating Income 196.98M 160.07M 173.09M 153.62M
Net Income -244,205,508 -198,451,428 144.22M 131.68M
Gross Margin 67.7% 67.7% 56.7% 56.7%
Operating Margin 14.1% 12.7% 20.0% 18.3%
Profit Margin -17.5% -16.6% 16.6% 15.7%
Rev Growth +10.8% +10.8% +3.7% +6.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 511.94M 511.94M 1.67B 1.31B
Total Equity 1.63B 1.63B 2.65B 2.44B
D/E Ratio 0.31 0.31 0.63 0.54
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 225.80M 193.68M 227.62M 227.59M
Free Cash Flow 128.87M 109.61M